NASDAQ (usa) | 6715.56 | -12.11 | -0.18% | |
FTSE 100 (london) | 7487.96 | -5.12 | -0.07% | |
DAX (german) | 13465.51 | 235.94 | 1.78% | |
NIKKEI 225 (japan) | 22420.08 | 408.47 | 1.86% | |
Hang - Seng (hong kong) | 28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) | 3391.61 | 17.53 | 0.52% | |
KOSPI (korea) | 2556.47 | 33.04 | 1.31% | |
All Ordinaries (australia) | 6005.30 | 28.90 | 0.48% | |
BOVESPA (brazil) | 74092.76 | -215.73 | -0.29% |
CVRx Inc. Common Stock (NASDAQ: CVRX)
CVRX Technical Analysis
5
As on 9th Jun 2023 CVRX STOCK Price closed @ 14.81 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 8.01 & Strong Buy for SHORT-TERM with Stoploss of 9.36 we also expect STOCK to react on Following IMPORTANT LEVELS. |
CVRXSTOCK Price
Open | 14.97 | Change | Price | % |
High | 15.14 | 1 Day | -0.01 | -0.07 |
Low | 14.42 | 1 Week | 1.56 | 11.77 |
Close | 14.81 | 1 Month | 5.05 | 51.74 |
Volume | 287379 | 1 Year | 4.10 | 38.28 |
52 Week High 19.40 | 52 Week Low 4.70 |
NASDAQ USA Most Active Stocks
TSLA | 244.40 | 4.06% |
TTOO | 0.07 | -12.50% |
SOFI | 8.18 | 0.74% |
FFIE | 0.33 | 6.45% |
PONO | 1.72 | 2.38% |
AMD | 124.92 | 3.20% |
IDEX | 0.06 | 0.00% |
NKLA | 0.70 | 14.75% |
AMZN | 123.43 | -0.66% |
AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
CVRX Daily Charts |
CVRX Intraday Charts |
Whats New @ Bazaartrend |
CVRX Free Analysis |
|
CVRX Important Levels Intraday
RESISTANCE | 16.20 |
RESISTANCE | 15.75 |
RESISTANCE | 15.48 |
RESISTANCE | 15.20 |
SUPPORT | 14.42 |
SUPPORT | 14.14 |
SUPPORT | 13.87 |
SUPPORT | 13.42 |
CVRX Forecast May 2024
4th UP Forecast | 24.52 |
3rd UP Forecast | 21.41 |
2nd UP Forecast | 19.48 |
1st UP Forecast | 17.56 |
1st DOWN Forecast | 12.06 |
2nd DOWN Forecast | 10.14 |
3rd DOWN Forecast | 8.21 |
4th DOWN Forecast | 5.1 |
CVRX Weekly Forecast
4th UP Forecast | 17.91 |
3rd UP Forecast | 16.92 |
2nd UP Forecast | 16.30 |
1st UP Forecast | 15.69 |
1st DOWN Forecast | 13.93 |
2nd DOWN Forecast | 13.32 |
3rd DOWN Forecast | 12.70 |
4th DOWN Forecast | 11.71 |
CVRX Forecast2024
4th UP Forecast | 44.16 |
3rd UP Forecast | 34.75 |
2nd UP Forecast | 28.93 |
1st UP Forecast | 23.11 |
1st DOWN Forecast | 6.51 |
2nd DOWN Forecast | 0.69 |
3rd DOWN Forecast | -5.13 |
4th DOWN Forecast | -14.54 |
CVRx Inc. Common Stock ( NASDAQ USA Symbol : CVRX )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
CVRX Other Details
Segment | EQ | |
Market Capital | 341200768.00 | |
Sector | Healthcare | |
Industry | Medical Devices | |
Offical website | > echo $website ; ?> |
CVRX Address
CVRX Latest News
CVRX Business Profile
CVRx, Inc. develops an implantable technology for the treatment of high blood pressure/hypertension and heart failure patients. It offers BAROSTIM NEO, a neuro-modulation therapy that triggers the body's natural reflex to regulate blood pressure and the underlying causes of the progression of heart failure, which is delivered through a long-lasting implant system, and customized to each patient's individual therapy needs. The company serves patients and healthcare professionals. CVRx, Inc. was incorporated in 2000 and is based in Minneapolis, Minnesota. It has operations in the United States, the United Kingdom, the Netherlands, Italy, Germany, and internationally. Address: 9201 West Broadway Avenue, Minneapolis, MN, United States, 55445
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service